Publicaciones en las que colabora con Maximino Abraldes Lopez-Veiga (7)

2024

  1. Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration

    Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359

  2. Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab

    Pharmaceuticals, Vol. 17, Núm. 2

  3. The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration

    Pharmaceutics, Vol. 16, Núm. 1

2023

  1. Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration

    Investigative ophthalmology & visual science, Vol. 64, Núm. 13, pp. 34

2020

  1. Características clínicas, manejo y resultados de los pacientes con endoftalmitis estéril asociados con la inyección intravítrea de factores de crecimiento endotelial antivascular

    Archivos de la Sociedad Española de Oftalmologia, Vol. 95, Núm. 5, pp. 211-216

  2. Pharmacological advances in the treatment of age-related macular degeneration

    Current Medicinal Chemistry, Vol. 27, Núm. 4, pp. 583-598

2018

  1. Ultrasonographic findings in the vitreous of patients with age-related macular degeneration treated with intravitreal anti-vascular endothelial growth factor injections

    Retina, Vol. 38, Núm. 10, pp. 1962-1967